AAPL 154.88 +1.84 (+1.20%)MSFT 105.38 +0.38 (+0.36%)FB 130.65 -2.52 (-1.89%)ZNGA 3.95 +0.07 (+1.68%)NVDA 133.37 -0.29 (-0.22%)WBA 68.22 +0.16 (+0.24%)GOOG 1029.8 -7.78 (-0.75%)PIH 4.14 +0.25 (+6.43%)
AAPL 154.88 +1.84 (+1.20%)MSFT 105.38 +0.38 (+0.36%)FB 130.65 -2.52 (-1.89%)ZNGA 3.95 +0.07 (+1.68%)NVDA 133.37 -0.29 (-0.22%)WBA 68.22 +0.16 (+0.24%)GOOG 1029.8 -7.78 (-0.75%)PIH 4.14 +0.25 (+6.43%)

Financial Summary PTLA Quote Portola Pha

Portola Pharmaceuticals Inc. Quote

Portola Pharmac (PTLA)

17.30 0.21 Healthcare
Stock Performance rating :
Recommendation :
Strong Sell
Score :
C
Symbol PTLA
Price 17.30
Beta 1.51
Vol Avg 1.64 M
Mkt cap 2.00 B
Shares 60
Last Div Not Available
Div Yield 0.00%
DCF Unlevered -187.25 Strong Sell
DCF Levered -167.47 Strong Sell
ROE -82.30% Strong Sell
ROA -57.89% Strong Sell
Operating Margin -1186.96% Strong Sell
Debt/Equity 64.84% Buy
P/E -3.63 Strong Sell
P/B 2.99 Strong Buy
Company Profile

CEO

William Lis

Sector

Healthcare

Industry

Biotechnology

Exchange

Nasdaq Global Select

Description

Portola Pharmaceuticals Inc is engaged in the healthcare sector. It develops & commercializes novel therapeutics to combat thrombosis, hematologic disorders & inflammation.